Abiopharma

Integer Holdings Corporation - Integer Holdings Corporation Reports Second Quarter 2026 Results

Integer Holdings Corporation Reports Second Quarter 2026 Results

Indivior Reports Second Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance

Change - Change in Corporate Information: Change of Address of Registered Office and Share Registrar in Bermuda

Integer Holdings Corporation - Integer to Be Acquired by KKR in Transaction Valued at Approximately $5.7 Billion

CNH Industrial N.V. Reports Second Quarter 2026 Results

Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale

Diginex Announces Secured US$70 Million Funding Commitments and Extension of Long-Stop Date for Proposed Acquisition of Resulticks

Parsons Selected to Lead Design of South Carolinas I-526 Long Point Road Interchange Improvements Project

Integer to Be Acquired by KKR in Transaction Valued at Approximately $5.7 Billion

Change - Announcement of Cessation: Cessation of Independent Director - Mark Benedict Ryan

General Announcement: Proposed Exercise of Resale Option and Adjustment of Interest Rate for 2023 Third Tranche MTNs

Change - Announcement of Cessation: Cessation of Lead Independent Director - Andrew John Lord

General Announcement: INVESTOR PRESENTATION - AUGUST 2026

General Announcement: Conclusion of Board Meeting